A group of charities have announced $3 million in grants to fund four innovative research projects over two years, stemming from the 2026 Tauopathy Challenge Workshop.  

The Rainwater Charitable Foundation, in collaboration with the Alzheimer’s Association, the Aging Mind Foundation, and CurePSP, will fund the proposals based on their potential to advance understanding of tau biology. 

Tauopathies are a group of devastating neurodegenerative disorders driven by the abnormal accumulation of tau protein, including Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), and Alzheimer’s disease (AD).  

The funding will go to: 

  • Carlo Condello, University of California, San Francisco: This research aims to reveal the molecular heterogeneity of cell type-specific tau conformers in 4-repeat (4R) tauopathies such as PSP and CBD. 
  • Daniel Lee, University of Kentucky: This research investigates how the tau modification citrullination interacts with phosphorylation to influence tau structure, aggregation, and disease-associated forms of tau. 
  • Dr Edward Lee, University of Pennsylvania: This research investigates how tau fibres bundle together and interact with nearby cell structures in PSP with the hope of uncovering whether neurons, astrocytes, and oligodendrocytes generate distinct forms of tau pathology. 
  • Sue-Ann Mok, University of Alberta: This research examines aggregate structures in de novo and seeded tau aggregation reactions to rapidly identify specific tau modifications that help drive or disrupt the formation of disease-associated aggregate structures. 

“As the burden of neurodegenerative disease continues to grow, it’s paramount we invest in innovative science that can unlock new paths toward diagnosis, treatment, and prevention,” said Jeremy Smith, President of the Rainwater Charitable Foundation. “We are grateful to our partners for helping make these grants possible and are proud to support the progress of these investigators and the insights they may generate for patients and families affected by these debilitating diseases.”